195 related articles for article (PubMed ID: 31509051)
1. Prolonged QT Interval in Patients Receiving Psychotropic Medications.
Swenson RS; Murphy-Ende K
J Am Psychiatr Nurses Assoc; 2020; 26(4):344-353. PubMed ID: 31509051
[No Abstract] [Full Text] [Related]
2. Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study.
Hu J; McMillan SS; Theodoros T; Collins JC; El-Den S; O'Reilly CL; Wheeler AJ
BMC Psychiatry; 2022 Nov; 22(1):705. PubMed ID: 36380352
[TBL] [Abstract][Full Text] [Related]
3. Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patients.
Das B; Rawat VS; Ramasubbu SK; Kumar B
Therapie; 2019 Dec; 74(6):599-609. PubMed ID: 31053339
[TBL] [Abstract][Full Text] [Related]
4. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
5. Oral health impacts of medications used to treat mental illness.
Cockburn N; Pradhan A; Taing MW; Kisely S; Ford PJ
J Affect Disord; 2017 Dec; 223():184-193. PubMed ID: 28759866
[TBL] [Abstract][Full Text] [Related]
6. QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update.
Beach SR; Celano CM; Sugrue AM; Adams C; Ackerman MJ; Noseworthy PA; Huffman JC
Psychosomatics; 2018; 59(2):105-122. PubMed ID: 29275963
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic medication use in children and adolescents in an inpatient setting.
Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.
Rhee TG; Rosenheck RA
J Affect Disord; 2019 Jun; 252():450-457. PubMed ID: 31004825
[TBL] [Abstract][Full Text] [Related]
9. [Psychotropic drugs].
Müller-Spahn F
Ther Umsch; 1999 Dec; 56(12):719-25. PubMed ID: 10638279
[TBL] [Abstract][Full Text] [Related]
10. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
Curran S; Turner D; Musa S; Wattis J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
12. Psychopharmacology in pregnancy.
Gjere NA
J Perinat Neonatal Nurs; 2001 Mar; 14(4):12-25. PubMed ID: 11930520
[TBL] [Abstract][Full Text] [Related]
13. Adverse Drug Reactions Associated with Antipsychotics, Antidepressants, Mood Stabilizers, and Stimulants.
Givens CJ
Nurs Clin North Am; 2016 Jun; 51(2):309-21. PubMed ID: 27229284
[TBL] [Abstract][Full Text] [Related]
14. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
Fontanella CA; Bridge JA; Campo JV
Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
[TBL] [Abstract][Full Text] [Related]
15. QTc prolongation, torsades de pointes, and psychotropic medications.
Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
[TBL] [Abstract][Full Text] [Related]
16. Prescription of psychiatric medications and polypharmacy in the LAMS cohort.
Kowatch RA; Youngstrom EA; Horwitz S; Demeter C; Fristad MA; Birmaher B; Axelson D; Ryan N; Frazier TW; Arnold LE; Young AS; Gill M; Findling RL
Psychiatr Serv; 2013 Oct; 64(10):1026-34. PubMed ID: 23852186
[TBL] [Abstract][Full Text] [Related]
17. High-risk psychotropic medications for US children with trauma sequelae.
Barnett ER; Concepcion Zayas MT
Epidemiol Psychiatr Sci; 2019 Aug; 28(4):360-364. PubMed ID: 30392479
[TBL] [Abstract][Full Text] [Related]
18. Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy.
Kalayjian A; Laszlo K; Fassler M; Schonrock Z; Delarose KE; Ly AM; English CD; Cirrincione LR
J Am Pharm Assoc (2003); 2024; 64(1):283-289.e2. PubMed ID: 37839699
[TBL] [Abstract][Full Text] [Related]
19. Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study.
Brett J; Daniels B; Karanges EA; Buckley NA; Schneider C; Nassir A; McLachlan AJ; Pearson SA
Br J Clin Pharmacol; 2017 Nov; 83(11):2581-2588. PubMed ID: 28689375
[TBL] [Abstract][Full Text] [Related]
20. Novel psychotropic medications in children: new toxicities to master.
Jacobs ES; Dickstein DP; Liebelt EL
Pediatr Emerg Care; 2001 Jun; 17(3):226-31. PubMed ID: 11437154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
